Murine transgenic cells lacking DNA topoisomerase IIbeta are resistant to acridines and mitoxantrone: analysis of cytotoxicity and cleavable complex formation.
about
Targeting DNA topoisomerase II in cancer chemotherapyEnhanced etoposide sensitivity following adenovirus-mediated human topoisomerase IIalpha gene transfer is independent of topoisomerase IIbetaThe topoisomerase IIbeta circular clamp arrests transcription and signals a 26S proteasome pathwayHistone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatinAmsacrine as a topoisomerase II poison: importance of drug-DNA interactions.Impact of Anthocyanidins on Mitoxantrone-Induced Cytotoxicity and Genotoxicity: An In Vitro and In Vivo Analysis.Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotterMechanisms of Action and Reduced Cardiotoxicity of Pixantrone; a Topoisomerase II Targeting Agent with Cellular Selectivity for the Topoisomerase IIα Isoform.The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothingTopoisomerase II and leukemia.Chd7 is indispensable for mammalian brain development through activation of a neuronal differentiation programme.Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents.Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II.NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform.C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells.Role of Topoisomerase IIβ in DNA Damage Response following IR and Etoposide.Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.26 S proteasome-mediated degradation of topoisomerase II cleavable complexes.Overexpression of the atypical protein kinase C zeta reduces topoisomerase II catalytic activity, cleavable complexes formation, and drug-induced cytotoxicity in monocytic U937 leukemia cells.Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt(II)-methionine coordination chemistry.TOP2B: The First Thirty Years
P2860
Q24649711-7177BC50-172A-45C4-83E6-1DCADA0B332CQ28348262-57FB4A3E-4E12-4276-84F6-863D4FD54D23Q34868039-53368226-14CD-4F4B-ABF7-D31FE4071E36Q35015901-3097D91E-01A7-4BD1-B560-4E0E391EC0F8Q35788447-8B6006E9-8650-4C95-B209-8CE032AD3860Q36008657-5EE5FDD2-A76B-4886-B833-29909542E129Q36326965-3B8CC9EF-DC4B-4432-A8F0-AFA5814EA7EAQ36559677-BD15C4B6-4F98-4F14-BFCC-06C853D0CCCCQ37108461-F97BB099-7BC6-4F8C-9410-C878ED8E7395Q37652882-DD352D7E-6465-462B-AC6F-3B784ECDDA70Q37719291-2E22E7A1-1C06-499A-916A-20CAD5C3AF27Q38029323-853D64A7-6A6D-4831-9856-B957566B68F5Q38801085-2DDDF2FF-F2B0-4593-A493-E42AD788F38FQ40075000-AF1F3932-C729-4D2E-9A67-A5C00EF49296Q40127799-35A295B0-91F7-4AF9-AD59-36A807DA084DQ40862150-EF461D07-3CCD-4C24-8501-3CF68F300EC1Q41762821-379F0DC6-B1EE-4312-BB3D-41A8A68A7213Q41882926-FD1F3ACA-48F5-4848-93C8-A31B3A4DAE80Q42234159-D3889980-F226-4FAF-A6F5-67235746BBD4Q43730370-2B1F09C1-F56B-4350-AC28-3959DABF2A14Q44053798-35332F78-36D4-42BC-8B0F-113C1D50C0A1Q47699480-BAA38448-BFF6-4FCF-9D02-36392922362EQ58738913-5708FCBF-C82D-4BAA-B3D9-9B5942C92FBC
P2860
Murine transgenic cells lacking DNA topoisomerase IIbeta are resistant to acridines and mitoxantrone: analysis of cytotoxicity and cleavable complex formation.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Murine transgenic cells lackin ...... d cleavable complex formation.
@en
Murine transgenic cells lackin ...... d cleavable complex formation.
@nl
type
label
Murine transgenic cells lackin ...... d cleavable complex formation.
@en
Murine transgenic cells lackin ...... d cleavable complex formation.
@nl
prefLabel
Murine transgenic cells lackin ...... d cleavable complex formation.
@en
Murine transgenic cells lackin ...... d cleavable complex formation.
@nl
P2093
P4510
P356
P1476
Murine transgenic cells lackin ...... d cleavable complex formation.
@en
P2093
Baguley BC
Errington F
Willmore E
P304
P356
10.1124/MOL.56.6.1309
P577
1999-12-01T00:00:00Z